The Live Wire



Press Release

New research shows statins are effective and safe

23 November 2011

A new study, largely funded by us, has highlighted the long-term benefits and safety of cholesterol-busting statins.

The research involved an 11-year follow-up study on people taking statins and showed the drug, in this case simvastatin, was safe, with no increase in cancer cases or deaths from other, non heart-related causes.

Our Medical Director, Professor Peter Weissberg, said: “This trial gives a very reassuring message for people taking statins. It shows the benefits of statins lasted throughout the whole 11 years of a follow-up study and that there is no evidence of any serious unexpected side effects.

“The findings also tell us that most of the benefits of statins are achieved in the first few months of treatment. Because of this research, people who are deemed by their doctor to be at a high risk of a heart attack or stroke should be started on a statins promptly and should continue to take them indefinitely.”

The study, involving 20,000 people at increased risk of heart or circulatory disease, was published in the Lancet.

The report is available here http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(11)61125-2/fulltext



Press releases, papers and documents published on this page are the intellectual property of an organisation unrelated to Central Lobby. We promote their parliamentary and political campaigning activities as they are subscribers to the Central Lobby service.

As such, Central Lobby does not edit, endorse, or attempt to balance the opinions expressed on this page. The content of press releases and other such types of content are the responsibility of the originating organisation.

More from Dods

© Dods Parliamentary Communications Ltd